Call for Proposals

DBT-BIRAC Joint Call for Proposals on ‘Precision Biotherapeutics-Cell and Gene Therapy’ for Fostering High Performance Biomanufacturing under BioE3 Policy

Cell and Gene Therapy (CGT) has been identified as one of the priority areas under the ‘Precision Biotherapeutics’ vertical of the BioE3 Policy for ‘fostering high performance Biomanufacturing’. The CGT sector is a rapidly evolving field with transformative potential for treatment of a range of complex and previously untreatable diseases. The potential of this emerging therapeutic modality is highlighted by the increasing number of CGTs which have been approved and are also in the development pipeline.

Eligibility: Eligible Organizations: 1Academic Organisations: Proposals may be submitted by interested applicants engaged in research activities at various Institutions/Universities/Societies/ Trusts/NGOs/Foundations/ Voluntary Organizations, recognized as a Scientific and Industrial Research Organization (SIRO). 2. Industry: Eligibility criteria for the Industries will be as per “Implementation Plan for the Biomanufacturing and Biofoundry Initiative”.

 Last date: Saturday, March 15, 2025